Jul. 16 at 2:03 PM
$GRAL Its crashing on low volume. a great buying opportunity for those who missed the ride earlier. Tricare revenue is picking steam, cash burn slowing down, Pathfinder 2 is looking strong, FDA submission on time, approval for population similar to Tricare high risk patients is looking good. just buy and hold for 5 years.